Anti- XXXX IgM and anti-delta screening by EIA method.

@entity82 @entity1956 @entity409 @entity157 @entity13210 @entity3619 @entity99
The clinical value of an enzyme-linked immunosorbent assay (ELISA) for the detection of anti- @entity13210 IgM was evaluated by testing 202 sera from @entity1956 ( @entity1956 ), @entity1956 ( @entity1956 ), @entity3619 (CAH), @entity409 ( @entity409 ), @entity82 , primary @entity157 , HBsAg carrier, @entity99 ( @entity99 ), @entity99 ( @entity99 ), non-A, non-B (NANB) @entity99 and miscellaneous conditions other than @entity99 , and 19 additional various @entity99 cases were examined for anti-delta. In clinical situations the accurate diagnosis of @entity1956 is not always possible and the differential diagnosis seems to be very important especially in making decisions of treatment and estimation of prognosis. In overall cases the highest positive rate of anti- @entity13210 IgM was found in @entity1956 as shown as 74.3% (26/35) comparing to other conditions in which the positive rate was extremely low (2.1%). The anti- @entity13210 IgM appeared to be highly specific to @entity1956 (83.9%) as compared to the other. The positive rate of HBsAg was high in @entity1956 , CAH and HBsAg carrier (100.0%) followed by @entity409 , @entity82 and @entity1956 (up to 70.8%). The ALT activities and ALPalb fractions were significantly high in @entity1956 (p less than 0.005). The correlation between the positivity of anti- @entity13210 IgM and highly abnormal ALT appeared be high. @entity1956 was confined mostly to 10-20 age group and the male to female ratio was about 6 to 1. Subgroup of @entity1956 II with positive anti- @entity13210 IgM appeared to have a greater chance being positive for HBsAg and ALPalb. The S/N ratio of anti- @entity13210 IgM was as high as 20 which was unique to @entity1956 .(ABSTRACT TRUNCATED AT 250 WORDS)
